Concepedia

Shane Colborne

SC

16

Publications

864

Citations

13

H-Index

2017

Active since

Affiliations

University of British Columbia(Current)

Canada's Michael Smith Genome Sciences Centre

BC Cancer Agency

Vancouver General Hospital

Translational Genomics Research Institute

Shane Colborne is an author at University of British Columbia specializing in medicine, pathology, and oncology.

Top concepts

Publications per year

2017–2024

16

Publications

16

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Karama Asleh, Gian Luca Negri, Sandra E. Spencer Miko et al. · Nature Communications · 2022 · 126 citations · Full text

, , +18

Class I <scp>HDAC</scp> inhibitors enhance <scp>YB</scp> ‐1 acetylation and oxidative stress to block sarcoma metastasis

Amal M. El-Naggar, Syam Prakash Somasekharan, Yemin Wang et al. · EMBO Reports · 2019 · 110 citations · Full text

Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

Haifeng Zhang, Christopher S. Hughes, Wei Li et al. · Cancer Discovery · 2021 · 104 citations · Full text

The histone methyltransferase <scp>EZH2</scp> is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type

Yemin Wang, Shary Yuting Chen, Anthony N. Karnezis et al. · The Journal of Pathology · 2017 · 103 citations · Full text

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Yemin Wang, Shary Yuting Chen, Shane Colborne et al. · Molecular Cancer Therapeutics · 2018 · 74 citations · Full text

Rows per page

1–5 of 16